This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
ADSTILADRIN
ANKTIVA
Bladder Cancer Detection
CORE-001 Study
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
BOND-003 Cohort P
CORE-008
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SUO 2024
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Conference Highlights
SIU 2017
SIU 2017 Kidney Cancer
Conferences
SIU 2017
Prostate Cancer
Kidney Cancer
Bladder Cancer
AUA 2014
Viewing 81-100 of 174 articles
#AUA14 - Statin use for dyslipidemia is associated with improved oncologic outcomes of surgically treated renal cell carcinoma - Session Highlights
#AUA14 - Characterizing the dominant/index lesion in prostate cancer: Implications for grading and staging - Session Highlights
#AUA14 - Longitudinal analysis of PSA doubling time following radical prostatectomy (RP) - Session Highlights
#AUA14 - Early detection of prostate cancer recurrence following radical prostatectomy: The role of 18F-choline PET/CT - Session Highlights
#AUA14 - Gleason score 6 prostate cancer and presence of pathological stage T3 disease - Session Highlights
#AUA14 - Validation of the Renal Pelvic Score: A novel marker of renal pelvic anatomy that predicts urine leak following partial nephrectomy - Session Highlights
#AUA14 - State-of-the-Art Lecture: Transitional urology: Adult care of the pediatric urology patient - Session Highlights
#AUA14 - Challenges in the contemporary management of spinal cord injured patients: Panel discussion - Session Highlights
#AUA14 - Comparison of toxicity between single modality radiation therapy and combined modality radiation therapy among low-risk prostate cancer patients - Session Highlights
#AUA14 - Cryo Online Data Registry Outcomes: Minimum five year follow up data - Session Highlights
#AUA14 - Invasion of prostatic capsule: Can preoperative mp-MRI predict the information of pathological analysis - Session Highlights
#AUA14 - A more extensive pelvic lymph node dissection is associated with improved survival of patients with node-positive prostate cancer - Session Highlights
#AUA14 - A novel genetic model for studying uric acid stone disease - Session Highlights
#AUA14 - Do circulating tumor cells help in decision-making regarding adjuvant chemotherapy in patients with urothelial carcinoma of the bladder treated with radical cystectomy? - Session Highlights
#AUA14 - Mental health is not affected by active surveillance for patients with small renal masses: Quality of life results from the DISSRM registry - Session Highlights
#AUA14 - Poster: Comparison of toxicity between single and combined modality radiation therapy among low-risk prostate cancer patients
#AUA14 - National trends in the management of benign renal masses: A 14-year survey of the Nationwide Inpatient Sample - Session Highlights
#AUA14 - High incidence of predominant Gleason pattern 4 is associated with low testosterone serum level in localized prostate cancer: An update with 937 patients - Session Highlights
#AUA14 - Session Highlights: Long term follow-up of a large active surveillance cohort
#AUA14 - Multiparametric prostate MRI and MRI/ultrasound fusion biopsy in the follow-up of prostate cancer progression for men on active surveillance - Session Highlights
1
2
3
4
5
6
7
8
9
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free